TABLE OF CONTENTS
Volume 38, Issue 4 (October 1985)
Original Articles |
Letters to the Editor |
List of Reviewers |
Notes of the American Society for Clinical Pharmacology and Therapeutics |
USAN Council
Commentary
The computerized on-line Medicaid pharmaceutical analysis and surveillance system: A new resource for postmarketing drug surveillance
Brian L Strom MD, MPH, Jeffrey L Carson MD, M Lee Morse PharmB and Aida A LeRoy PharmD Philadelphia, Pa., Camden, N.J., and Arlington, Va.
Clin Pharmacol Ther 38: 359-364; doi:10.1038/clpt.1985.188
Original Articles
Morphine-induced skin wheals: A possible model for the study of histamine release
Roberto Saucedo MD and Sergio Erill MD Granada, Spain
Clin Pharmacol Ther 38: 365-370; doi:10.1038/clpt.1985.189
Interactions between ethanol and oral contraceptive steroids
Joy Hobbes MSc, John Boutagy PhD and Gillian M Shenfield DM St. Leonards, Australia
Clin Pharmacol Ther 38: 371-380; doi:10.1038/clpt.1985.190
The acute effects of acrivastine (BW825C), a new antihistamine, compared with triprolidine on measures of central nervous system performance and subjective effects
A F Cohen MD, M Hamilton PhD, R Philipson and A W Peck PhD Kent, United Kingdom
Clin Pharmacol Ther 38: 381-386; doi:10.1038/clpt.1985.191
Sulindac metabolism: The importance of an intact colon
H A Strong BSc, N J Warner, A G Renwick PhD and C F George MD Southampton, United Kingdom
Clin Pharmacol Ther 38: 387-393; doi:10.1038/clpt.1985.192
A family study of genetic and environmental factors determining polymorphic hydroxylation of debrisoquin
E Steiner MD, L Iselius MD, G Alván MD, J Lindsten MD and F Sjöqvist MD Stockholm, Sweden
Clin Pharmacol Ther 38: 394-401; doi:10.1038/clpt.1985.193
Interethnic differences in genetic polymorphism of debrisoquin and mephenytoin hydroxylation between Japanese and Caucasian populations
K Nakamura MD, F Goto MD, W A Ray PhD, C B McAllister MS, E Jacqz MD, G R Wilkinson PhD and R A Branch MD Nashville, Tenn., and Tsukuba, Japan
Clin Pharmacol Ther 38: 402-408; doi:10.1038/clpt.1985.194
Pharmacokinetics and beta-blocking effects of timolol in poor and extensive metabolizers of debrisoquin
John C McGourty MB, Joseph H Silas MD, Jude J Fleming PhD, Alan McBurney MPhil and John W Ward MB Merseyside and Leicester, United Kingdom
Clin Pharmacol Ther 38: 409-413; doi:10.1038/clpt.1985.195
Stereoselective mephobarbital hydroxylation cosegregates with mephenytoin hydroxylation
A Küpfer PhD and R A Branch MD Nashville, Tenn., and Bern, Switzerland
Clin Pharmacol Ther 38: 414-418; doi:10.1038/clpt.1985.196
Effects of long-term therapy with naltrexone on body weight in obesity
Richard L Atkinson MD, Lisa K Berke MSN, FNP, Charles R Drake MD, Mary Lynn Bibbs MSN, FNP, Frederick L Williams MD and Donald L Kaiser PhD Charlottesville, Va.
Clin Pharmacol Ther 38: 419-422; doi:10.1038/clpt.1985.197
Terazosin kinetics after oral and intravenous doses
Sean E Patterson PhD Abbott Park, Ill.
Clin Pharmacol Ther 38: 423-427; doi:10.1038/clpt.1985.198
Ventilatory effects of atenolol and bevantolol in asthma
Jan-Willem J Lammers MD, Hans T M Folgering MD and Cees L A van Herwaarden MD H. Landstichting, The Netherlands
Clin Pharmacol Ther 38: 428-433; doi:10.1038/clpt.1985.199
Antihypertensive and cardiovascular effects of nitrendipine: A controlled study vs. placebo
Liberato Aldo Ferrara MD, Maria Luisa Fasano MD, Giovanni de Simone MD, Stefano Soro MD and Renato Gagliardi BSc Naples, Italy
Clin Pharmacol Ther 38: 434-438; doi:10.1038/clpt.1985.200
Pefloxacin kinetics in cirrhosis
Gaby Danan MD, Guy Montay, Rober Cunci MD and Serge Erlinger MD Clichy and Alfortville, France
Clin Pharmacol Ther 38: 439-442; doi:10.1038/clpt.1985.201
Inhibition of prostaglandin synthesis by indomethacin interacts with the antihypertensive effect of atenolol
Pauli Ylitalo MD, Timo Pitkäjärvi MD, Maija-Liisa Pyykönen MD, Anna-Kaisa Nurmi MSc, Erkki Seppälä MD, MSc and Heikki Vapaatalo MD Tampere, Finland
Clin Pharmacol Ther 38: 443-449; doi:10.1038/clpt.1985.202
Transdermal nicotine reduces cigarette craving and nicotine preference
Jed E Rose PhD, Joseph E Herskovic PhD, Yvonne Trilling and Murray E Jarvik MD, PhD Los Angeles, Calif.
Clin Pharmacol Ther 38: 450-456; doi:10.1038/clpt.1985.203
Pharmacokinetics of high-dose pentobarbital in severe head trauma
Charles D Bayliff PharmD, Michael L Schwartz MD and Brian G Hardy PharmD Toronto, Ontario, Canada
Clin Pharmacol Ther 38: 457-461; doi:10.1038/clpt.1985.204
Pharmacokinetics of a new angiotensin I converting enzyme inhibitor (alacepril) after oral dosing in fasting or fed states
Kaoru Onoyama MD, Hideki Hirakata MD, Hiroshi Tsuruda MD, Nobuaki Ohchi MD, Suguru Tomooka MD, Kenichi Motomura MD, Teruo Omae MD, Kouji Hayashi PhD and Masatoshi Fujishima MD Fukuoka, Japan
Clin Pharmacol Ther 38: 462-468; doi:10.1038/clpt.1985.205
New insights into the pharmacokinetics of spironolactone
Hans W P M Overdiek PharmD, Walter A J J Hermens BS and Frans W H M Merkus PhD Sittard and Amsterdam, The Netherlands
Clin Pharmacol Ther 38: 469-474; doi:10.1038/clpt.1985.206
Letters to the Editor
Concomitant food intake does enhance the bioavailability and effect of hydralazine
A Melander MD, H Liedholm MD and A McLean MD
Clin Pharmacol Ther 38: 475; doi:10.1038/clpt.1985.207
Reply
Alexander M M Shepherd MD, PhD and Thomas M Ludden PhD
Clin Pharmacol Ther 38: 475-476; doi:10.1038/clpt.1985.208
List of Reviewers
Top of pageNotes of the American Society for Clinical Pharmacology and Therapeutics
Notes of the American Society for Clinical Pharmacology and Therapeutics
Clin Pharmacol Ther 38: 478; doi:10.1038/clpt.1985.210
